Information  X 
Enter a valid email address

Primary Health Props (PHP)

  Print      Mail a friend

Friday 07 December, 2018

Primary Health Props

Director/PDMR Shareholding

RNS Number : 8711J
Primary Health Properties PLC
07 December 2018
 

 

Primary Health Properties PLC

 

Director shareholding

 

The Company has been advised today that the following information relating to the transaction below has been filed with the FCA in accordance with Article 19(1) of the Market Abuse Regulation

 

1

Details of Person Discharging Managerial Responsibility/person closely associated with them ("PCA")

(a)

Name

Harry Hyman

 

2

Reason for the notification

(a)

Position/status

Managing Director

(b)

Initial notification/ amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

(a)

Name of Entity

 

Primary Health Properties PLC

(b)

Legal Entity Identifier

213800Y5CJHXOATK7X11

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument

Ordinary shares of 12.5p

ISIN: GB00BYRJ5J14

(b)

Nature of the transaction

Acquisition in monthly share plan

 

(c)

Price(s) and volume(s)

Price(s)

Volume(s)

£1.106

88

(d)

Aggregated information

Aggregated volume price

Single transaction

£97.32

(e)

Date of transaction

4 December 2018

 

(f)

Place of transaction

London Stock Exchange (xlon)

 

 

 

 

For further information:

 

Primary Health Properties PLC

Paul Wright, Nexus Management Services Limited, Company Secretary

+44(0) 20 7451 7050


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHBUBDDDXGBGIR

a d v e r t i s e m e n t